QPT Share Price

Open 0.14 Change Price %
High 0.14 1 Day 0.01 7.69
Low 0.14 1 Week 0.01 7.69
Close 0.14 1 Month 0.01 7.69
Volume 5000 1 Year 0.08 133.33
52 Week High 0.19
52 Week Low 0.04
QPT Important Levels
Resistance 2 0.14
Resistance 1 0.14
Pivot 0.14
Support 1 0.14
Support 2 0.14
CVE Canada Most Active Stocks
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
More..
CVE Canada Top Gainers Stocks
TUF 0.02 100.00%
AZU 0.02 100.00%
AZU 0.02 100.00%
ADE 0.02 100.00%
BVQ 0.02 100.00%
DDX 0.50 100.00%
RDM 0.21 90.91%
RDM 0.21 90.91%
PMC 0.06 50.00%
PMC 0.06 50.00%
More..
CVE Canada Top Losers Stocks
TCI 0.08 -55.56%
TCI 0.08 -55.56%
TCI 0.08 -55.56%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
More..

Quest PharmaTech Inc (CVE: QPT)

QPT Technical Analysis 4
As on 24th Apr 2017 QPT Share Price closed @ 0.14 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.09 & Strong Buy for SHORT-TERM with Stoploss of 0.12 we also expect STOCK to react on Following IMPORTANT LEVELS.
QPT Target for April
1st Target up-side 0.16
2nd Target up-side 0.18
3rd Target up-side 0.2
1st Target down-side 0.1
2nd Target down-side 0.08
3rd Target down-side 0.06
QPT Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.questpharmatech.com
QPT Address
QPT
8123 Roper Road NW
Edmonton, AB T6E 6S4
Canada
Phone: 780-448-1400
Fax: 780-416-0324
QPT Latest News
Bellus Skin Rejuvenation Serum: Quest PharmaTech Launches Scientifically ...   Canada NewsWire (press release)   - 14th Nov 16
Quest PharmaTech Inc. Retains Haft Group for Financial Services   PR Newswire (press release)   - 06th Sep 16
Quest PharmaTech Announces Filing of Restated Audited Financial Statements for ...   Canada NewsWire (press release)   - 06th Aug 16
Quest PharmaTech's Subsidiary, OncoQuest, Signs Agreement with Shenzhen ...   PR Newswire (press release)   - 22nd Mar 16
Quest PharmaTech Receives US $2 Million for its Immuno-Photodynamic Therapy Assets   Business Wire (press release)   - 10th Dec 15
Quest PharmaTech's Subsidiary, OncoQuest, Closes US $13000000 Preferred Share ...   PR Newswire (press release)   - 18th Nov 15
Quest PharmaTech Announces Funding Support from National Research Council's ...   PR Newswire (press release)   - 13th Jan 15
Quest PharmaTech to Market and Distribute Premium Anti-Wrinkle Skin Care ...   PR Newswire (press release)   - 22nd Oct 14
Quest PharmaTech Signs License Agreement With Bioceltran Co., Ltd. for ...   Marketwired (press release)   - 02nd Oct 14
Quest PharmaTech Initiates Phase II Oregovomab Front-Line Chemo-Immunotherapy ...   PR Newswire (press release)   - 14th Jun 12
Interactive Technical Analysis Chart Quest PharmaTech Inc ( QPT CVE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Quest PharmaTech Inc
QPT Business Profile
Quest PharmaTech Inc., a clinical stage biotechnology company, engages in the development and commercialization of oncology products. It develops a portfolio of product candidates for the treatment of cancer by combining immunotherapeutic antibodies with chemotherapy, immune-adjuvants, and photodynamic therapy. The company's lead product candidate, Oregovomab, an immunotherapeutic product for the treatment of ovarian cancer and is under a multi-center Phase IIb clinical trials in Italy and the United States. The company also develops MUC1 program that has completed phase I clinical trials for the treatment of cancer tumors; and SL052, a photosensitizer product, which is under phase I clinical trials and is intended for the treatment of prostate cancer. Quest PharmaTech Inc. has a strategic relationship with with AD Biotech Co., Ltd. The company is headquartered in Edmonton, Canada.